Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease

Vincent Ries1, Claire Henchcliffe, Tatyana Kareva

  • 1Department of Neurology, Columbia University College of Physicians and Surgeons, 650 West 168th Street, New York, NY 10032, USA.

Insights

Gene therapy using adeno-associated virus (AAV) to activate Akt signaling shows promise for treating neurodegenerative diseases like Parkinson's. This approach offers neuroprotection and promotes neuron health by bypassing delivery challenges of traditional neurotrophic factors.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Gene Therapy

Background:

  • Neurotrophic factors show potential for neurodegenerative diseases but face delivery challenges.
  • Activating intracellular signaling pathways offers an alternative therapeutic strategy.
  • Parkinson's disease affects dopamine neurons in the substantia nigra.

Purpose of the Study:

  • To evaluate the efficacy of viral vector-mediated activation of intracellular neurotrophic signaling pathways.
  • To assess the neuroprotective and restorative effects of adeno-associated virus (AAV) encoding a constitutively active Akt (Myr-Akt) in dopamine neurons.

Main Methods:

  • Adeno-associated virus type 1 (AAV1) vector transduction was used to deliver the Myr-Akt gene.
  • The study targeted dopamine neurons in the substantia nigra of adult and aged mice.
  • Neuroprotection was assessed using a neurotoxin model of cell death.

Main Results:

  • AAV-mediated Myr-Akt transduction demonstrated significant trophic effects on dopamine neurons.
  • Observed effects included increased neuron size, enhanced phenotypic markers, and promoted sprouting.
  • Transduced neurons exhibited near-complete protection against apoptotic cell death induced by neurotoxins.

Conclusions:

  • Direct activation of intracellular neurotrophic signaling pathways via vector transfer is a feasible therapeutic approach.
  • This strategy holds potential for neuroprotection and restorative treatments in neurodegenerative diseases.
  • AAV-Myr-Akt shows promise for Parkinson's disease therapy by supporting dopamine neuron survival and function.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...